Ronald Seger
Optometrist · Mountain View, CANPI 1417910290
Payments from drug & device makers
Across 106 payments — averaging $52.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$4K
- Maculogix, Inc.$465
- Johnson & Johnson Vision Care, Inc.$348
- Topcon Healthcare, Inc.$224
- Optovue, Inc.$203
- Alcon$166
- plus $477 from 8 others
What the payments were for
- Consulting fees$5009%
- Travel & lodging$82815%
- Food & beverage$2,63647%
- Education$1,50027%
- Entertainment$1392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 67 | $3,721 |
| Maculogix, Inc. | 3 | $465 |
| Johnson & Johnson Vision Care, Inc. | 11 | $348 |
| Topcon Healthcare, Inc. | 1 | $224 |
| Optovue, Inc. | 3 | $203 |
| Alcon | 9 | $166 |
| Optos, Inc. | 4 | $139 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $108 |
| Visioneering Technologies, Inc. | 1 | $96 |
| ABB Con-cise Optical Group LLC | 2 | $41 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Dompe US, Inc. | 1 | $23 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
| Plexus Optix, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$1,500
- Non-Product Brand Specific$1,246
- AdaptDx$391
- OCT MAESTRO$224
- BIOTRUE ONE DAY$108
- ULTRA$108
How this compares
$5,603 in reported general payments places this provider in the 90th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 20 | $364 |
| Timolol Maleate | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Mountain View
- Meng LinBerkeley$6.9M
- Steve YoelinNewport Beach$6.1M
- Matthew GellerSpring Valley$3.5M
- David Kasanoffla Mesa$1M
- Colton HeinrichFullerton$987K
- Elsa PaoOakland$910K
- Keith WanSan Diego$887K
- Selena ChanSan Francisco$677K
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.